BETTY REYES-RESTREPO: Open Payments
NPI 1043649155 · CARROLLTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 37 payments from 12 companies in 2025. Trend: 2023 $655 · 2024 $259 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $158 |
| Novo Nordisk Inc | 9 | $146 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Amgen Inc. | 3 | $47 |
| Dexcom, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Abbott Laboratories | 1 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: UBRELVY, Ozempic, QULIPTA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, Wegovy, JARDIANCE, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
